Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


MaxDiscovery™ Mouse Granzyme B ELISA Test Kit

Product Description
The MaxDiscovery™ Mouse Granzyme B ELISA Test Kit is designed for quantitative determination of the concentration of mouse granzyme B in serum, plasma, and cell culture supernatant. Mouse granzyme B is a ~25 kDa protein of 227 amino acids (aa) after cleavage of a 20 aa signal peptide. It is a member of the Granzyme family of exogenous serine proteases and is one of the eleven Granzymes (A,B,C,D,E,F,G,K,M,N,O) found in the mouse genome. Granzymes are released by cytoplasmic granules within cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. Their purpose is to induce apoptosis within virus-infected tumorigenic cells, thus destroying them. Granzyme B works in conjunction with the protein perforin to induce apoptosis in target cells by forming transmembrane pores and through cleavage of effector caspases such as caspase-3. A caspase-independent mechanism of granzyme B-mediated apoptosis has also been suggested. Granzyme B may have roles in rheumatoid arthritis and in bacterial and viral infections. Measuring granzyme B release in response to the appropriate target is useful for evaluating cell-mediated cytotoxicity.
Product MaxDiscovery™ Mouse Granzyme B ELISA Test Kit
Company BIOO Scientific - Product Directory
Price Request a quote
More Information View company product page
Catalog Number 2014-01
Quantity 1 x 96 wells
Company Logo

BIOO Scientific - Product Directory
3913 Todd Lane Suite 312 Austin, TX 78744, USA

Tel: +1 512-707-8993
Fax: +1 512-707-8122
Email: info@biooscientific.com



Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Protein-Based “Cancer Signature” Uncovered
Researchers investigated the expression of ribosomal proteins in human tissues and discovered a cancer type specific signature which could be used to predict the progression of the disease.
Ribosome Recycling as a Drug Target
Researchers explain mechanism that recycles bacterial ribosomes stalled on messenger RNAs that lack termination codons.
Predicting Leukaemia Development in Cancer Patients
Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia.
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Toxoplasma’s Balancing Act Explained
Parasite’s method of rewiring our immune response leads to novel tool for drug tests.
Cancer Signaling Pathway Illuminating Way To Therapy
Researchers refine a pro-growth signalling pathway, common to cancers, that can kill cancer cells while leaving healthy cells unharmed.
Breast Cancer Cells Starve for Cystine
Depriving triple negative breast cancer, a treatment-resistant form of breast cancer, of cystine results in cancer cell death.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!